Mauro Cives

14PUBLICATIONS
42CO-AUTHORS
ChemotherapyPredictive and prognostic markersCancer geneticsNon-genetically modified uses of biotechnologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Apr 10, 2026
Cabozantinib and temozolomide in patients with advanced progressive neuroendocrine tumors: a phase 2 study.

Mauro Cives, Giuseppina Della Vittoria Scarpati, Ottavia Clemente

|Nov 19, 2025
Bone metastases from neuroendocrine neoplasms: Results of an Italian nationwide survey of natural history and management.

Nicola Fazio, Patrick Maisonneuve, Anna Maria Frezza

|Jul 28, 2025
White paper on best practices for translational research in neuroendocrine neoplasms.

Jerome Cros, Oriol Casanovas, Justo P Castaño

|Jul 09, 2024
Is NETTER-2 a practice-changing trial?

Jonathan Strosberg, Mauro Cives

|Apr 13, 2024
Sequencing Treatments in Patients with Advanced Well-Differentiated Pancreatic Neuroendocrine Tumor (pNET): Results from a Large Multicenter Italian Cohort.

Francesco Panzuto, Elisa Andrini, Giuseppe Lamberti

|Dec 23, 2023
Extrapulmonary Neuroendocrine Carcinomas: Current Management and Future Perspectives.

Sara Stumpo, Maria Giovanna Formelli, Irene Persano

Pageof 3

Frequent Collaborators

3 joint publications

Marco Tucci

2 joint publications

Francesco Mannavola

2 joint publications

Salvatore Tafuto

2 joint publications

Giuseppe Lamberti